Invitae Spinal Muscular Atrophy STAT Panel
Test analyzes SMN1 copy number to diagnose SMA and reports SMN2 copies when SMN1 is deleted. A rapid 4-day STAT TAT supports urgent treatment decisions.
Accessed through the SMA Identified Sponsored Testing Program•Sponsored by Biogen•Performed by Invitae | Labcorp
Designed to support clinical decision-making and ordering in your practice.
For healthcare providers
Overview
The SMA Identified program offers sponsored testing to assist in diagnosing SMA or determining carrier status, with three panel options available to match patient needs. Genetic confirmation is often required before initiating therapy, and the program helps streamline that process. Biogen funds the program but never receives identifiable patient data from testing.
When to consider this test
Patient selection
- Providers may order testing for patients in the US and Puerto Rico who meet one or more of the following:
- Clinical suspicion of SMA or a prior SMA diagnosis without known SMN2 copy number
- No current diagnosis but a documented family history of SMA
- First-degree relatives of individuals diagnosed with SMA through genetic testing
Workflow
How to use this program
- 1
Order Test
Confirm eligibility, review testing with the patient, obtain consent, and place the order through Invitae’s online portal.
- 2
Collect Sample
Collect the patient’s specimen using the Invitae kit and return it using the prepaid US shipping label.
- 3
Review Results
Access results online and use available resources to guide discussions with your patient about their results.
Billing overview
Program billing
For eligible patients, the sponsor has arrangements with the laboratory that may reduce or cover some or all of the patient's out-of-pocket cost. Actual cost and patient responsibility vary by program criteria. Refer to lab or sponsor materials for details.
Quality & privacy
Laboratory quality & data handling
Testing is performed by Invitae | Labcorp, a CLIA-certified laboratory (CLIA 05D2040778). Your sample is processed using validated methods and quality controls to support reliable genetic results.
Your health information is handled under privacy and security practices that are intended to align with applicable regulations. For program- and lab-specific details, review the privacy information provided by the laboratory and sponsor.
FAQ
Frequently asked questions
Who can order testing through SMA Identified?
Any US-based provider caring for a patient who has a suspected or confirmed SMA diagnosis, a family history of SMA, or is a first-degree relative of someone with an SMA genetic diagnosis.
What tests are available through this program?
Providers may choose from three Invitae SMA testing options, including the STAT SMN1/SMN2 copy number analysis, depending on clinical need.
Are there age restrictions?
No. The program is open to individuals of any age within the US and Puerto Rico.
What supporting information should be submitted?
When available, providers should include clinical notes, family history, or newborn screening results to assist in variant interpretation.
Are there obligations to Biogen or Invitae?
No. While Biogen financially supports the program, neither providers nor patients are required to recommend, prescribe, or use any product associated with the sponsor.
See an issue with this program?